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Abstract 
 
D-Serine, an endogenous coagonist of the N-methyl-D-aspartate receptor 
(NMDAR), is widely distributed in the central nervous system and is synthesized from 
L-serine by serine racemase (SR).  NMDAR plays an important role in pain processing 
including central sensitization that eventually causes hyperalgesia.  To elucidate the 
roles of D-serine and SR in pain transmission, we evaluated the behavioral changes and 
spinal nociceptive processing induced by formalin using SR knock-out (KO) mice.  
We found that SR is mainly distributed in lamina II of the dorsal horn of the spinal cord 
in wild-type (WT) mice.  Although the formalin injected subcutaneously induced the 
biphasic pain response of licking in SR-KO and WT mice, the time spent on licking was 
significantly longer in the SR-KO mice during the second phase of the formalin test.  
The number of neurons immunopositive for c-Fos and phosphorylated extracellular 
signal-regulated kinase (p-ERK), which are molecular pain markers, in laminae I-II of 
the ipsilateral dorsal horn was significantly larger in the SR-KO mice.  
Immunohistochemical staining revealed that the distribution of SR changed from being 
broad to being concentrated in cell bodies after the formalin injection.  On the other 
hand, the expression level of the cytosolic SR in the ipsilateral dorsal horn significantly 
decreased.  Oral administration of 10 mM D-serine in drinking water for one week 
cancelled the difference in pain behaviors between WT and SR-KO mice in phase 2 of 
the formalin test.  These findings demonstrate that the SR-KO mice showed increased 
sensitivity to inflammatory pain and the WT mice showed translocation of SR and 
decreased SR expression levels after the formalin injection, which suggest a novel 
antinociceptive mechanism via SR indicating an important role of D-serine in pain 
transmission. 
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1.  Introduction 
 
D-Serine, an endogenous coagonist of the N-methyl-D-aspartate receptor (NMDAR), 
is widely distributed in the central nervous system (CNS) and is synthesized by the 
biosynthetic enzyme serine racemase (SR) [1,2,3].  By binding at the glycine binding 
site of NMDAR with an agonist, glutamate, D-serine efficiently activates NMDAR 
[4,5,6].  By modulating neurotransmission through NMDAR, D-serine plays important 
roles under physiological and pathophysiological conditions including synaptic 
plasticity, learning and memory, and neuronal toxicity [7,8,9,10]. 
Involvement of NMDAR in pain transmission has been the focus of much research 
in terms of central sensitization, the process for the establishment of the hyperexcitable 
state in the spinal cord that leads to enhanced responses to nociceptive stimuli [11].  
Under repetitive noxious stimulation, excitatory postsynaptic currents (EPSCs) 
generated by glutamatergic transmission from nociceptors summate in postsynaptic 
neurons and activate NMDAR.  NMDAR activation causes calcium influx, which 
modulates synaptic strength that leads to the enhancement of nociceptive transmission 
and development of hyperalgesia [12,13].  NMDAR antagonists, on the other hand, 
abolish or prevent the state of hyperexcitability induced by central sensitization [14].  
The NMDAR antagonist ketamine has been applied as an effective analgesic adjunct for 
postoperative pain in humans [15]. 
NMDAR is basically composed of NR1 and NR2 (A - D) subunits and forms a 
heterotetramer between two NR1 subunits and at least one of other NR2 subunits [16].  
The NR1 subunits are distributed throughout the gray matter of the spinal cord, whereas 
the NR2A subunit is concentrated in laminae III and IV and the NR2B subunit in 
lamina II of the dorsal horn [17,18].  The NR2B subunit in lamina II, where 
nociceptive fibers terminate, is involved in neuronal plasticity and pain transmission 
[19,20,21].  The antagonists selective to the NR2B subunits administered intrathecally 
attenuate the pain response in inflammatory and neuropathic pain models [22,23].   
Because the distribution of D-serine in the brain closely matches that of NMDAR, 
particularly that containing the NR2B subunit [1,24], it has been postulated that 
D-serine is involved in pain transmission. 
The lines of evidence of the contribution of D-serine in pain transmission are, 
however, controversial.  In the studies using transgenic mice lacking D-amino acid 
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oxidase (DAO), an enzyme that catalyzes the oxidative deamination of D-amino acids, 
Wake et al. reported that pain-related responses in the formalin test were augmented 
[25], whereas Zhao et al. reported that they were attenuated [26].  DAO inhibitors 
administered intrathecally attenuated and reversed formalin-induced pain-related 
responses [27].  D-Serine directly applied to the rat dorsal horn increased 
NMDAR-mediated EPSCs [28].  Intrathecal administration of D-serine facilitated the 
tail flick reflex in response to thermal stimuli [29], and antagonized the antinociceptive 
effect of gabapentin [30] and lidocaine [31], or did not affect formalin-induced pain 
behavior [32]. 
In this study, we evaluated the behavioral changes and the spinal nociceptive 
processing in response to the inflammatory pain induced by formalin using SR 
knock-out (KO) mice as the control to elucidate the role of endogenous D-serine in pain 
transmission. 
 
This doctoral thesis is based on our recent publication (Tabata-Imai et al. 2014 [33]) 
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2.  Materials and Methods 
 
2.1. Ethics statement  
The animal care and experimental protocol were approved by the Animal 
Experiment Committee of the University of Toyama (Approval number: A2011 
MED-7) and were carried out in accordance with the Guidelines for the Care and Use of 
Laboratory Animals of the University of Toyama.  Tissue sampling was performed 
under overdosing with sodium pentobarbital or halothane, and all efforts were made to 
minimize suffering.  
 
2.2. Animals 
Generation and genotyping of SR-KO and wild-type (WT) control mice with 
the pure C57BL/6 genetic background have been reported [34].  Adult (3 - 5 months) 
age-matched SR-KO and WT male mice were used in this study.  Because diurnal 
circadian rhythm [35], ambient temperature [36], and acute stress [37,38] affect the pain 
threshold, the entire experiment was performed from 10:00 a.m. to 4:00 p.m. at room 
temperature (RT) between 21.5 and 24.5ºC, after acclimatizing the mice to the 
experimental environment.  The experiment was also performed with chemical restrain 
using the anesthetic halothane before formalin injection.   
 
2.3. Antibodies and reagents  
The primary antibodies and staining reagents used in immunohistochemical 
analysis were as follows: 1) the mouse monoclonal anti-SR antibody (BD Biosciences; 
1:100), 2) the mouse monoclonal anti-NeuN antibody [Chemicon (Millipore); 1:100], 3) 
the rabbit anti-c-Fos antibody (Santa Cruz Biotechnology; 1:5,000), 4) the rabbit 
anti-p-ERK antibody (Cell Signaling Technology; 1:500), and 5) the rabbit 
anti-microtubule-associated protein 2 (anti-MAP2) antibody (Millipore; 1:100).  The 
secondary antibodies used were Alexa-488- and Alexa-594-labeled species-specific 
antibodies (Invitrogen; 1:500).  All the primary and secondary antibodies were diluted 
with 1% bovine serum albumin (BSA) in phosphate-buffered saline (PBS).  
FITC-conjugated isolectin IB4 (Vector Laboratories; 1:50 in PBS) was used for staining 
lamina II of the dorsal horn.   For blocking nonspecific signals in the prepared tissue 
sections, 10% donkey normal serum in PBS was used.  For p-ERK staining, 0.3% 
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Triton-X 100 was added to the blocking and antibody-diluting solutions.   
The primary antibodies used in western blot analysis were 1) the rabbit 
anti-SR antibody (1:500) [39], 2) the rabbit anti-actin antibody (Santa Cruz 
Biotechnology; 1:5,000), and 3) the rabbit anti-transferrin receptor (anti-TfR) antibody 
(Millipore; 1:1,000).  Horseradish peroxidase (HRP)-conjugated anti-rabbit IgG 
(Bio-Rad; 1:10,000) was used as the secondary antibody.   
 
2.4. Immunohistochemical analysis  
Mice were deeply anesthetized with sodium pentobarbital (100 mg/kg body weight, 
IP) and transcardially perfused with ice-cold PBS followed by 4% paraformaldehyde in 
PBS.  The mice used in the formalin injection study were euthanized with halothane 
(4%) after the experiment.  Their spinal cords were harvested without perfusion 
fixation to avoid the possible loss of immunohistochemical signals and postfixed in 4% 
paraformaldehyde in PBS at 4ºC overnight.  After cryoprotection with 30% sucrose in 
0.1 M phosphate buffer, the lumbar enlargements of the spinal cords were cut and 
embedded in O.T.C. mounting medium (Tissue-Tek, Sakura Finetek Japan Co., Ltd., 
Tokyo).  The spinal cords were transversally cut into 20-mm-thick sections with a 
cryostat (LEICA CM1850, Leica Instruments GmbH, Germany) and the sections from 
L4 – L5 were morphologically identified under a light microscope. 
Sections for staining with mouse monoclonal antibodies were pretreated with a 
mouse Ig blocking reagent (Vector Burlingame, CA).   Sections for staining with an 
anti-p-ERK antibody were pretreated by permeabilization with ice-cold methanol and 
incubation at -20°C for 10 min.  After 1 h incubation at RT with the blocking solution, 
tissue sections were incubated with primary antibodies described above at 4ºC overnight.  
Sections were incubated with secondary antibodies for 1 h at RT.  To identify lamina 
II of the dorsal horn, the sections were incubated with FITC-conjugated IB4 at RT for 1 
h.  All the sections were counterstained with 4’, 6-diamidino-2-phenylindole (DAPI) 
for cell nuclear visualization and coverslipped.  Images were taken using a confocal 
laser scanning microscope, Leica TCS-SP5 (Leica Microsystems, Mannheim, 
Germany). 
 
2.5. Formalin test 
Nine WT and eleven SR-KO mice were used for the formalin test.  The 
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animals were individually handled for a week before the experiment to acclimatize them 
to the experimental environment.  The formalin test was performed in accordance with 
the method described by Malmberg and Yaksh [40].  The mice were lightly 
anesthetized with halothane and 20 µl of 5% formalin solution (formaldehyde solution, 
Sigma-Aldrich; concentration was adjusted using sterile saline) was injected 
subcutaneously into the dorsal surface of the left hind paw using a 30-gauge needle.  
The mice were individually placed in a mirror-backed Plexiglass chamber (25 x 25 x 20 
cm3) for observation.  After a brief recovery period (less than 2 min), the mice showed 
normal motor function, and then pain and other spontaneous nonpain behaviors were 
observed and video-recorded for 120 min.  The durations of pain and nonpain 
behaviors were analyzed over periods of 1 - 5 min and 6 - 10 min, and at 10 min 
intervals after that until 120 min.  The mice were euthanized with halothane (4%) 30 
min after the formalin test, and their spinal cords were sampled for further analysis.   
For the formalin test after oral administration of D-serine, nine WT and ten 
SR-KO mice were used.  D-Serine (Wako, Japan) was dissolved in water at 10 mM 
and was administered to the WT and SR-KO mice with drinking water for one week.  
The formalin test and pain behavioral analysis were performed as described above.   
 
2.6. Behavioral analysis 
Mouse behaviors observed during the formalin test were analyzed using the 
recorded video images.  Licking of the formalin-injected paw was considered as a pain 
behavior [41] and the time spent on licking was visually determined in units of seconds.  
Other spontaneous behaviors, such as walking (moving forward or backward on four 
limbs), rearing (standing on hind legs with the stifle extended), grooming, and 
crouching, were considered to be nonpain behaviors and the duration was determined in 
units of seconds.  Behaviors were analyzed by an experimenter who was blind to the 
genotype of the mice used in the study.   
 
2.7. Counting of c-Fos- and p-ERK-immunopositive neurons in dorsal horn of mice 
after formalin test 
The spinal cords harvested 30 min after the formalin test were processed for 
immunohistochemical analysis using the following primary antibodies: mouse 
monoclonal anti-NeuN, rabbit polyclonal anti-cFos, and rabbit polyclonal anti-p-ERK 
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antibodies.  Neurons were identified by staining with the anti-NeuN antibody.  All 
the sections were counterstained with DAPI for cell nuclear visualization.   
Five SR-KO and five WT mice were used in this study.  Four nonadjacent 
sections from the L4 - L5 lumbar spinal cord from each mouse were randomly selected 
before the examination of c-Fos and p-ERK immunostaining.  The images of c-Fos 
and p-ERK staining in the dorsal horn ipsilateral to the formalin-injected hind paw were 
evaluated.  When c-Fos or p-ERK staining in a cell was colocalized with nuclear 
staining (DAPI), the cell was counted as c-Fos- or p-ERK-positive.  The numbers of 
c-Fos-positive cells within the IB4-stained area and p-ERK-positive cells in laminae I-II 
were manually counted.  
 
2.8. Western blot analysis of membrane and cytosolic fraction samples from dorsal 
horn of lumbar spinal cord ipsilateral to formalin-injected hind paw of WT mice 
Nine WT mice were used in this study.  The mice were lightly anesthetized 
with halothane, and 20 µl of 5% formalin solution was injected into the left hind paw as 
in the formalin test described above.  The mice were grouped into three, and their 
spinal cords were sampled 0 min, 30 min, and 90 min after the injection.  The dorsal 
horn of the lumbar spinal cord ipsilateral to the injection site was processed using the 
method described by Huttner et al. [42,43] and Balan et al. [42,43] with slight 
modifications as follow.  A sample of the dorsal horn ipsilateral to the injection site 
from each mouse was homogenized in HEPES-buffered sucrose [320 mM sucrose, 4 
mM HEPES/NaOH (pH7.3)] supplemented with protease inhibitors (Protease Inhibitor 
Cocktail, Nacalai Tesque, Kyoto, Japan) using a homogenizer.  The homogenate was 
centrifuged at 1,200 x g for 15 min at 4ºC to remove cell nuclei and debris.  The 
supernatant was centrifuged at 200,000 x g for 120 min at 4ºC to obtain cytosolic and 
membrane fractions.  Protein extracts of 11 - 20 µg (the same weight for each 
electrophoresis run) were fractionated by SDS-PAGE and fractionated proteins were 
transferred onto a polyvinylidine difluoride (PVDF) membrane.  After blocking with 
5% skim milk in PBS containing 0.1% Tween-20, the PVDF membrane was incubated 
with rabbit anti-SR, rabbit anti-actin, and rabbit anti-TfR antibodies at 4ºC overnight.  
Following the incubation with the appropriate secondary antibody for 40 min at RT, 
protein bands were detected using an ELC chemiluminescence detection system (Image 
Quant LAS 400 mini, GE Healthcare, Sweden).  The detected protein bands were 
 11 
quantified using Image Quant TL software (GE Healthcare, Sweden). 
 
2.9. Measurement of SR fluorescence intensity in somata of neurons in dorsal horn 
after formalin injection in WT mice 
Six WT mice were used in this study.  The mice were lightly anesthetized 
with halothane, and 20 µl of 5% formalin solution was injected into the left hind paw as 
in the formalin test described above.  The mice were grouped into three and their 
spinal cords were sampled 0 min, 30 min, and 90 min after the injection.  The L4 - L5 
spinal cords were processed for double immunohistochemical analysis using mouse 
monoclonal anti-SR and rabbit polyclonal anti-MAP2 antibodies as the primary 
antibodies.  All the sections were counterstained with DAPI for cell nuclear 
visualization.  The immunopositivity for SR and MAP2 in the dorsal horn ipsilateral to 
the injection site was evaluated.  In the set of images obtained from 0 min and 90 min 
after formalin injection, ten cells that showed the colocalized signals of SR and MAP2 
were selected for further analysis.  The regions of interest (ROIs) were set as an ellipse 
(the longest diameter; 7.9 ± 0.3 µm) around the selected cells and the fluorescence 
intensities of SR and MAP2 within the ROI were measured using the publicly available 
Java image-processing program ImageJ (National Institute of Health, Bethesda, MD). 
 
2.10. Statistical analyses 
All numerical data are presented as means ± S.E.M.  The data of the formalin test were 
examined by two-way repeated measures analysis of variance (RM ANOVA followed 
by the Tukey-Kramer post-hoc test as indicated.  Differences in the numbers of c-Fos- 
and p-ERK-positive cells in the dorsal horn between the SR-KO and WT mice, and the 
fluorescence intensity of SR 0 min and 90 min after formalin injection were compared 
by the unpaired Student’s t-test.  The SR protein expression levels in the cytosolic and 
membrane fractions 0 min, 30 min, and 90 min after formalin injection were compared 
by one-way ANOVA followed by the Tukey-Kramer post-hoc test as indicated.  In all 
comparisons, values of p < 0.05 were considered significant. 
 
 
 
 
 12 
3.  Results 
 
3.1. Serine racemase in the spinal cord was distributed mainly in lamina II of the 
dorsal horn  
In the central nervous system, SR is predominantly distributed in neurons of 
the cerebral cortex, olfactory bulb, olfactory tubercle, hippocampus, and striatum, and is 
weakly expressed in the cerebellum and brain stem [34].  We first examined the 
distribution pattern of SR in the spinal cord using SR-KO mice as the negative control.  
Immunofluorescence staining of SR revealed that SR was distributed mainly in the 
superficial part of the dorsal horn and was weakly expressed in the cell bodies in the 
ventral horn (Fig. 1-A).  At a higher magnification, SR signals were also found to 
colocalize with DAPI nuclear staining (Fig. S1).  In contrast, no SR signals were 
detected in the spinal cord of SR-KO mice (Fig. 1-B), suggesting the specificity of SR 
immunostaining in our study.  To determine the localization of SR in the dorsal horn in 
the Rexed laminae, we performed double fluorescence staining of SR and IB4, which 
binds nonpeptidergic afferents and terminates on the middle one-third of lamina II 
[44,45].  The double fluorescence staining demonstrated that SR in large amounts is 
distributed in laminae I - III and is concentrated in lamina II of the dorsal horn (Fig. 
1-C-E).              
 
3.2. SR-KO mice showed increased pain sensitivity in the second phase of the 
formalin test 
As a potent coagonist of NMDAR, SR in lamina II indicates that D-serine has a 
role in pain transmission, especially in relation to inflammation.  To elucidate the 
involvement of SR in nociceptive transduction, we conducted the formalin test, a model 
for inflammatory pain [41], using SR-KO and WT mice.   
Formalin subcutaneously injected into the hind paw induces a biphasic nociceptive 
response: immediate and intense responses with a transient quiescent period (phase 1: 1 
- 10 min) followed by a prolonged tonic response (phase 2: 11 - 120 min) [40,46].  
Phase 1 of the pain behavior (i.e., paw licking) is caused by the direct effect of formalin 
on nociceptors, which evokes intense but short-duration pain behavior, and phase 2 of 
the behavior is induced by inflammatory responses caused by formalin [40,47,48] and is 
prevented by NMDA antagonists [14].  Following the formalin injection, both WT and 
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SR-KO mice demonstrated typical biphasic responses.  The duration of the pain 
behavior, that is, licking on the formalin-injected paw, in phase 2 significantly increased 
in SR-KO mice (two-way RM ANOVA), WT vs SR-KO, F = 8.907, p < 0.01).  There 
were no significant differences in the intensity of the pain behavior between the SR-KO 
and WT mice in phase 1.  The licking duration in the SR-KO mice was significantly 
longer than that in the WT mice at 40, 100, and 110 min (Tukey-Kramer post-hoc test, p 
< 0.05), (Fig. 2-A).   
 In the formalin test, we investigated other behaviors that were not signs of 
pain: walking, rearing, grooming, and crouching.  There were significant differences 
between the WT and SR-KO mice in walking and rearing durations during phase 2 of 
the formalin test [two-way RM ANOVA, WT vs SR-KO, F = 8.045, p < 0.05 (walking), 
F = 9.313, p < 0.01 (rearing)].  The WT mice walked for a significantly longer time 
than the SR-KO mice at 20, 30, and 40 min of the observation period (Tukey-Kramer 
post-hoc test, p < 0.05), (Fig. 2-B).  The rearing durations of the WT mice were 
significantly longer at 20, 30, 80, and 110 min (Tukey-Kramer post-hoc test, p < 0.05), 
(Fig. 2-C).  There were no significant differences between the SR-KO and WT mice in 
grooming and crouching durations in the formalin test [two-way RM ANOVA, WT vs 
SR-KO, F = 0.61, p > 0.05 (grooming), F = 0.33, p > 0.05 (crouching); data not shown]. 
 
3.3. The nociceptive cells in the dorsal horn of SR-KO mice showed a markedly 
high activity during the formalin test 
To verify the changes in neuronal activity in the dorsal horn of the spinal cord, we 
conducted an immunohistochemical study using the antibodies to c-Fos and 
phosphorylated ERK (p-ERK).  c-Fos is the protein encoded by the protooncogene 
c-fos and has been extensively used as the marker of neuronal activity in pain [49,50,51].   
As an immediate early gene, the transcriptional activation of c-fos occurs within 
minutes after stimulation and the expression level of the protein peaks about 2 h after 
the induction of gene transcription.  The level of formalin-induced c-Fos expression 
returns to the baseline 8 - 24 h after formalin injection [51,52].  p-ERK has recently 
been commonly used as a nociceptive specific marker in many pain studies 
[52,53,54,55].  The p-ERK expression in response to noxious stimuli is reported to be 
transient: rapid onset and peaking at 2-10 min, and returning to the baseline 1-2 h after 
formalin injection [52,56].  The high p-ERK expression levels continue along with the 
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pain behaviors [53].  In our formalin test, the pain behavior of WT and SR-KO mice 
continued to 120 min.  Thus, we examined the p-ERK expression level 30 min after 
the behavioral test. 
Figures 3-A and B show the immunofluorescence staining pattern of c-Fos in the 
L4 - L5 spinal cord harvested 30 min after the behavioral test.  After the formalin 
injection into the left hind paw, c-Fos protein signals were observed in the ipsilateral 
dorsal horn of the spinal cord in the SR-KO and WT mice.  Double 
immunofluorescence staining of NeuN, a neuronal marker, showed the dense 
distribution of c-Fos-positive neurons in the superficial layers in the dorsal horn of the 
SR-KO and WT mice.  The number of c-Fos-positive neurons in laminae I-II, 
identified using IB4, was significantly larger in the SR-KO mice (n = 5, unpaired 
Student’s t-test, two-tailed, WT vs SR-KO, p < 0.05), (Fig. 3-C-E).   
p-ERK-positive cells were also observed in the ipsilateral dorsal horn of the spinal 
cord in SR-KO and WT mice (Fig. 4-A, B).  p-ERK was mainly distributed in lamina 
I-II of the dorsal horn, and the number of the p-ERK-positive neurons identified on the 
basis of NeuN  signals was significantly larger in the SR-KO mice  (n = 5, unpaired 
Student’s t-test, two-tailed, WT vs SR-KO, p < 0.01), (Fig. 4-C).  
 
3.4. Inflammatory stimuli decreased the cytosolic SR expression level in the 
ipsilateral dorsal horn and induced changes in SR localization in lamina II 
 Although D-serine is a potent coagonist of NMDAR, the mice lacking SR 
demonstrated increased sensitivity to inflammatory pain in our study.  To clarify the 
role of SR, we examined the effects of noxious stimuli on SR localization and 
expression patterns on the basis of the lines of evidence suggesting the feedback 
inactivation of D-serine synthesis by NMDAR activity, namely, the membrane 
translocation of SR and the degradation of SR itself [43,57,58]. 
We first evaluated the SR localization in the dorsal horn of L4 - L5 of the lumbar 
spinal cord from WT mice before and after the formalin test.  Immunofluorescence 
signals of SR were relatively uniformly distributed in lamina II in the control mice (Fig. 
5-A).  A magnified image of lamina II shows densely distributed SR signals (Fig. 5-C).  
In contrast, immunopositivity for SR was mainly detected in the cell bodies in lamina II 
of the ipsilateral dorsal horn 30 min after the formalin test (Fig. 5-B).  A magnified 
image of lamina II reveals that SR signals were concentrated in the cell bodies (Fig. 
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5-D).  These findings suggest that the formalin injection induced the changes in SR 
localization and expression level.  
To examine the temporal changes in the level of SR expression after the formalin 
injection, the ipsilateral dorsal horn of the lumbar spinal cord in WT mice was harvested 
0 min, 30 min, and 90 min after the formalin injection and the cytosolic and membrane 
fraction samples were prepared and analyzed by western blotting.  After the formalin 
injection, the SR expression level in the cytosolic fraction significantly decreased only 
90 min after the injection (one-way ANOVA, F = 14.847, p < 0.01, Tukey-Kramer 
post-hoc test, p < 0.05, Fig. 6-A, B).  The SR expression level in the membrane 
fraction tended to increase after the formalin injection, but there is no significant 
difference in membrane SR level among the groups examined at 0, 30, and 90 min 
(one-way ANOVA, F=1.89, p > 0.05, Fig. 6-C, D).  The expression level of the 
membrane SR relative to that of the total SR (cytosolic and membrane) showed no 
significant difference among the groups examined at 0 min, 30min, and 90 min 
(one-way ANOVA, F = 1.4235, p > 0.05, Fig. 6-E).   
For the detailed analysis of SR localization after formalin injection, 
immunohistochemical analysis was carried out using the sections from the L4 - L5 of 
the lumbar spinal cord harvested 0 min, 30 min, and 90 min after formalin injection.  
Immunofluorescence staining of SR indicated that the observed SR signals at lamina II 
of the dorsal horn at 0 min became weak 30 min after the formalin injection (Fig. 
7-A1-C1, D1-F1).  Double immunofluorescence staining of MAP2, the marker of 
neuronal somata and dendrites, revealed the colocalization of SR and MAP2 (Fig. 
7-A3-C3).  A magnified image of lamina II revealed that SR signals uniformly 
colocalized with MAP2 signals before the formalin injection, and the area of 
colocalization of SR and MAP2 signals decreased 30 min and 90 min after the formalin 
injection.  Most of the merged areas were observed in the cell body after the formalin 
injection (Fig. 7-D3-F3).  To compare the fluorescence intensity of SR in the cell body 
before and after the formalin injection, the fluorescence intensity of SR was normalized 
with MAP2 signal intensity.  We found that the signal of SR in the soma 90 min after 
formalin injection significantly increased (n = 10, unpaired Student t-test, 0 min vs 90 
min, p < 0.01, Fig. 7-G).    
 
3.5. Effect of exogenous D-serine on pain behavior in WT and SR-KO mice 
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To evaluate whether the D-serine deficit in SR-KO mice is responsible for the pain 
hypersensitivity, we conducted the formalin test after the administration of exogenous 
D-serine.  Because the administration of 10 mM D-serine in drinking water for one 
week significantly increased the spinal D-serine level in SR-KO mice [59], we 
conducted the formalin test one week after oral administration of 10 mM D-serine.  
Formalin subcutaneously injected into the hind paw induced typical biphasic responses 
in WT and SR-KO mice.  There were statistically no significant differences in the 
intensity of the pain behavior between SR-KO and WT mice during the formalin test  
(two-way RM ANOVA, F = 4.15, p = 0.06), (Fig. 8). 
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4.  Discussion 
 
The aim of this study was to identify the role of SR in nociceptive 
transmission in the dorsal horn of the spinal cord using the mutant mice lacking SR.  
The main findings of this study were as follows: 1) SR was mainly distributed in lamina 
II of the dorsal horn of the spinal cord in the WT mice, 2) the SR-KO mice showed 
increased sensitivity to inflammatory pain induced by formalin injected subcutaneously, 
3) the expression levels of the c-Fos and p-ERK proteins, the molecular markers of pain, 
significantly increased in laminae I-II of the ipsilateral dorsal horn neurons in SR-KO 
mice after the formalin test, 4) the immunopositivity level of SR decreased and the SR 
distribution pattern changed from being broad to being concentrated in cell bodies in 
lamina II after the formalin test, 5) the expression level of the SR protein significantly 
decreased in the cytosolic fraction 90 min after the noxious stimulation with formalin, 
6) SR colocalized with MAP2, a marker of neuronal somata and dendrites, and the area 
of colocalization changed from being broad to being concentrated in cell bodies in 
lamina II after formalin stimuli, 7) D-serine administration for one week cancelled the 
difference in pain behaviors between WT and SR-KO mice.  These findings indicate 
that SR in lamina II of the dorsal horn has the novel inhibitory role in pain transmission 
via modulation of SR localization and expression. 
 
4.1. SR expression pattern in spinal cord 
D-Serine in the brain exists at high levels in areas where NMDAR, 
particularly the NR2B-subunit-containing receptors, are abundant [24] and regulates 
NMDAR as a potent and dominant coagonist over another coagonist, glycine [5,60].  
Because the mutant mice without the SR protein show a marked decrease in the 
expression level of D-serine (10 – 20% of WT mice) in the brain [34,61,62] and because 
D-serine distribution closely correlates with that of SR [2,63], SR is a predominant 
enzyme for D-serine production [64].  Accordingly, SR has been considered an 
important enzyme for effective neurotransmission and synaptic plasticity via NMDAR 
activation.  Although its expression level is low, D-serine exists in the spinal cord and 
is most likely produced from SR [1,59,65].  In our study, SR was found to distribute 
mainly in sensory neurons in lamina II of the dorsal horn.  Nagy et al. 
immunohistochemically showed that among NMDAR subunits, the NR2B subunit is 
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mainly distributed in lamina II of the dorsal horn [18].  This coexpression of SR and 
the NR2B subunit in lamina II suggests that D-serine has an important contribution to 
sensory transmission, particularly pain sensation, through NMDAR activation. 
 
4.2. Formalin test  
To demonstrate the involvement of SR in the pain pathway, we examined the 
SR-KO and WT mice by the formalin test, which induces inflammation and 
C-fiber-specific responses resulting in the central sensitization that requires NMDAR 
activation [14,40,66].  We hypothesized that if D-serine in the dorsal horn is important 
for central sensitization, the SR-KO mice should show attenuated pain behavior in the 
second phase of the formalin test.  Contrary to the hypothesis, the SR-KO mice 
showed significantly enhanced pain behavior in the second phase.  The nonpain 
behaviors, such as walking and rearing, were reduced in the SR-KO mice.  Altogether, 
these findings confirm that SR-KO mice have increased sensitivity to inflammatory 
pain.    
Hypersensitivity to inflammatory pain seen in the SR-KO mice is further supported 
by the increased expression levels of the c-Fos and p-ERK proteins in laminae I-II of 
the ipsilateral dorsal horn.  Thirty minutes after the formalin test, the time when the 
expression level of c-Fos normally peaks and that of p-ERK continues, the numbers of 
c-Fos- and p-ERK-immunopositive cells were significantly larger in the SR-KO mice; 
therefore, the neuronal activity for nociceptive transmission is considered higher and the 
neuronal activation longer in the SR-KO mice.   
Although it has been reported that licking behavior itself increases the c-Fos 
expression level [67] and decreases the p-ERK expression level [68], the effect of 
licking on c-Fos and p-ERK expression levels was excluded in our study because not 
only the expression level of c-Fos but also that of p-ERK increased in the SR-KO mice.  
The intense and prolonged neuronal activation in response to the formalin injection 
reflects the prolonged pain behavior seen in the SR-KO mice, which reinforce the idea 
that the SR-KO mice have increased sensitivity to inflammatory pain.       
 
4.3. Inhibitory modulation by SR in pain pathway  
Our results clearly show that SR-KO mice have increased sensitivity to 
inflammatory pain, indicating that the presence of SR and possibly D-serine is required 
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for the proper inhibitory modulation in the pain pathway.  There are lines of evidence 
showing that D-serine production is regulated by the activation and inactivation of SR.  
Balan et al. reported that SR translocates from the cytosol to the membrane and is 
inactivated by palmitoylation to inhibit D-serine synthesis after NMDAR activation [43].  
Dumin et al. reported that the D-serine level is modulated via ubiquitin-dependent 
degradation of SR [57].  In our study, SR was found to colocalize with MAP2 and its 
distribution pattern changed from being broad to being concentrated in cell bodies after 
the formalin injection in the WT mice.  On the other hand, the expression level of the 
SR protein significantly decreased in the cytosolic fraction.  These findings indicate 
that the expression level of SR decreased and SR translocated into cell bodies after the 
formalin stimulation, suggesting that the feedback inactivation of D-serine synthesis was 
induced by formalin.  That is, the inflammatory pain stimulation by formalin in 
peripheral tissues is transmitted into lamina II of the dorsal horn via C-fibers and 
activates NMDAR; consequently, the translocation and degradation of SR, and the 
decrease in cytosolic SR expression level will be induced for the inactivation of 
D-serine synthesis to initiate the analgesic pathway.  The results of our formalin test 
after oral administration of D-serine for one week support this hypothesis.   Miyoshi et 
al. reported that oral administration of D-serine significantly increases the spinal 
D-serine level in SR-KO mice [59].  After oral administration of D-serine, the pain 
behavior in phase 2 of the formalin test was enhanced in both WT and SR-KO mice to 
the same degree.  This suggests that excess amount of D-serine in the spinal cord 
caused by D-serine administration cancelled the SR feedback inactivation system, which 
attenuates the excessive NMDAR activation. 
In SR-KO mice, the SR-regulated inhibitory control is absent and glycine is the 
only coagonist driving NMDAR.  Because D-serine activates NMDAR more 
efficiently than glycine does [5], it is presumable that the NMDAR barrage induced by 
formalin was more intense in the WT mice, at least at the beginning of the inflammatory 
pain transmission.  Nevertheless, the SR-KO mice showed hypersensitivity to 
inflammatory pain.  It is possible that an as yet compensatory mechanism by which the 
level of glycine increases in the spinal cord exists in SR-KO mice.  Furthermore, Basu 
et al. examined the decay kinetics of NMDAR-mediated excitatory postsynaptic current 
recording from hippocampal cells of SR-KO mice and suggested an enhanced 
contribution of NR2B-containing NMDAR in the juvenile stage of SR-KO mice [61].  
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Hence, because the NR2B subunit is involved in pain transmission [19,20,21,22,23], an 
enhanced contribution of NR2B-containing NMDAR could be another possible reason 
for the enhanced pain transmission seen in SR-KO mice.   
 Our results indicate the following novel hypothetical analgesic mechanism 
regulated by SR.  When noxious stimuli are transmitted to the dorsal horn, SR residing 
broadly in lamina II of the dorsal horn translocates to the cell body resulting in the 
inactivation of D-serine production.  At the same time, the expression level of SR in 
the cytosol decreases, which leads to decreased D-serine production, which in turn 
attenuates NMDAR activation and consequently alleviates nociceptive sensation. 
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6. Conclusion 
 
SR, which converts L-serine to the potent coagonist D-serine for NMDAR, is 
distributed in areas where NMDAR, especially its NR2B subunit, is abundant.  Under 
physiological condition, D-serine plays an important role in synaptic plasticity 
enhancing neurotransmission.  In this study, we illustrated the inhibitory modulation 
regulated by SR in the spinal pain pathway.  This is a novel mechanism of the 
analgesic pathway for inflammatory pain.  With the effective agents blocking D-serine 
production, this inhibitory pathway may provide future analgesic strategies for 
controlling inflammatory pain. 
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Figure 1.  Distribution of immunofluorescence staining of serine racemase (SR) in 
lumbar spinal cord.   (A) SR (green) is mainly distributed in the superficial part of 
the dorsal horn of the WT mice.  (B) No SR signals (green) are detected in the spinal 
cord of the SR-KO mice.  The dorsal part is the upper side.  The bar indicates 100 µm 
in A and B.  (C-E) The double immunofluorescence staining of SR (green) and IB4 
(magenta), a marker of lamina II of the dorsal horn, indicates that SR is predominantly 
distributed in lamina II.  The bar indicates 75 µm in C-E.  The dotted lines in A and B 
are the outline of the gray matter of the spinal cord. 
 
 
 
 
 
 
 
 
 
                     
Figure 2.  SR-KO mice show significantly enhanced pain behavior during the formalin 
test.  Data from the SR-KO (n = 11, closed square) and WT (n = 9, opened square) mice are 
the durations of licking (A) of the formalin-injected paw (a pain behavior), and walking (B) and 
rearing (C) (nonpain behaviors) after formalin injection.  Data are collected at 5 min intervals 
until 10 min after the formalin injection (0 min), then at 10 min intervals until the end of the 
observation period (120 min).  (A) Formalin injected subcutaneously into the hind paw 
induced biphasic pain responses: an acute temporal but intense licking followed by a short 
pause (1-10 min; phase 1), and prolonged continuous tonic licking during the observation period 
(11-120 min; phase 2).  There is no significant difference in licking duration between the 
SR-KO and WT mice in phase 1.  However, the SR-KO mice showed significantly enhanced 
pain behavior in the early (40 min) and late (100 and 110 min) stages of phase 2.  (B) In the 
early stage (20, 30, and 40 min) of phase 2, the WT mice walked significantly longer than the 
SR-KO mice.  There is no significant difference in walking duration between the SR-KO and 
WT mice in phase 1.  (C) The WT mice showed a significant increase in rearing duration in 
phase 2, especially in the early (20 and 30 min) and late (80 and 110 min) stages.  There is no 
significant difference in rearing duration between the SR-KO and WT mice in phase 1.  Values 
are the means ± SEM.  Data were analyzed by two-way RM ANOVA followed by the 
Tukey-Kramer post-hoc test; * p < 0.05. 
                 
 
 
 
Figure 3.  The number of c-Fos-positive neurons in the SR-KO mice significantly 
increased after the formalin test.  (A, B) Immunohistochemical analysis indicates that 
formalin injected into the left hind paw induced c-Fos protein signals (yellow) in the ipsilateral 
dorsal horn neurons detected together with NeuN signals (blue) in the WT (A) and SR-KO (B) 
mice.  The c-Fos-positive neurons are mainly distributed in the superficial layers in the dorsal 
horn.  Bars indicate 100 µm.  (C, D) Double immunofluorescence staining with IB4 
(magenta) indicates that the c-Fos-positive (yellow) neurons are mainly distributed in laminae 
I-II of the dorsal horn.  Bars indicate 100 µm.  Dotted lines in A – D are the outline of the 
gray matter of the spinal cord. (E) The number of c-Fos-positive cells in laminae I-II 
significantly increased in SR-KO mice.  Values are the means ± SEM.  Data are analyzed 
using the unpaired t-test; * p < 0.05 (n = 5 for WT and SR-KO mice). 
 
 
 
 
                 
 
 
  
 
Figure 4.  The number of p-ERK-positive neurons in SR-KO mice significantly increased 
after the formalin test.  (A, B) Immunohistochemical analysis indicates that formalin injected 
into the left hind paw induced p-ERK signals (magenta) at the surface of the ipsilateral dorsal 
horn of the WT and SR-KO mice.  Dotted lines in A and B are the outline of the gray matter of 
the spinal cord.  The bar indicates 75 µm.  (C) The number of p-ERK-positive neurons in 
laminae I-II significantly increased in the SR-KO mice.  Values are the means ± SEM.  Data 
are analyzed by the unpaired t-test; ** p < 0.01 (n = 5 for WT and SR-KO mice). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
               
 
 
  
Figure 5.  The distribution of SR in the dorsal horn changed after the formalin test.  (A, 
C) Before the formalin injection, SR (green) was uniformly distributed in lamina II of the dorsal 
horn of the lumbar spinal cord in the WT mice.  An enlarged image of lamina II demonstrates 
a relatively dense distribution of SR signals particularly in cell bodies.  Bars indicate 50 µm.  
(B, D) Thirty minutes after the formalin test, the density of immunofluorescence SR signals in 
the ipsilateral dorsal horn decreased.  A magnified image of lamina II revealed that the signals 
of SR concentrated in cell bodies (D).  Bars indicate 50 µm.  Dotted lines in A and B are the 
outline of the gray matter of the spinal cord. 
 
 
 
 
 
 
 
 
 
 
 
 
       
 
  
 
Figure 6.  Cytosolic and membrane SR in the ipsilateral dorsal horn changed after the 
formalin test.  Western blot analysis of SR in cytosolic and membrane fraction samples from 
ipsilateral dorsal horn of lumbar spinal cord in WT mice was performed 0 min, 30 min, and 90 
min after formalin injection.  (A) Western blot analysis of the cytosolic fraction revealed the 
decrease in SR protein expression level after formalin injection.  (B) The relative SR 
expression level 90 min after the injection significantly decreased from the control level.  The 
expression level of the SR protein was normalized to that of actin.  (C) SR expression levels in 
membrane fraction before and after formalin injection.  (D) Relative SR expression level after 
formalin injection.  The expression level of the SR protein was normalized to that of the 
transferrin receptor protein (TfR).   (E) Relative change in SR expression level in membrane 
fraction to those in cytosolic and membrane fractions after formalin injection.  The positions of 
protein size markers are indicated on the right side (A, C).  Values are the means ± SEM.  
Data are analyzed by one-way ANOVA followed by Tukey-Kramer post-hoc test; * p < 0.05  
(n = 3 for WT and SR-KO mice). 
              
Figure. 7  Immunofluorescence localization of SR in ipsilateral dorsal horn changes after 
formalin injection.  (A-C) In WT mice, SR (green) is predominantly distributed in lamina II 
of the dorsal horn before formalin injection (0 min), and its signal density decreases over time 
after the injection (A1-C1).  Double immunofluorescence staining of SR (green) and 
microtubule-associated protein 2 (MAP2) (red, A2-C2) indicates that SR and MAP2 colocalize 
in lamina II of the dorsal horn.  The merged signals of SR and MAP2 are broadly distributed in 
the control (A3-C3).  The bar indicates 75 µm in A - C.  (D-F) Magnified image of areas of 
SR and MAP2 colocalization before and after formalin injection.  Signals of SR and MAP2 are 
merged and densely distributed before formalin injection (D3).  After formalin injection, the 
density of merged signals of SR and MAP2 increased in cell bodies and decreased around the 
cell bodies (E3, F3).  The bar indicates 25 µm in D-F.  (G) The relative fluorescence intensity 
of SR in cell bodies 90 min after the formalin injection significantly increased from the control 
level.  The fluorescence intensity of the SR protein was normalized to that of MAP2.  AU, 
arbitrary units.  Values are the means ± SEM.  Data are analyzed by the unpaired t-test; ** p 
< 0.01 (n = 10 for 0 min and 90 min). 
                   
 
 
  
 
Figure 8.  Effect of exogenous D-serine on pain behavior in WT and SR-KO mice.  Data 
from the SR-KO (n = 10, closed square) and WT (n = 9, opened square) mice are the durations 
of licking of formalin-injected paw (a pain behavior) after formalin injection.  Data are 
collected at 5 min intervals until 10 min after the formalin injection (0 min), then at 10 min 
intervals until the end of the observation period (120 min).  Formalin injected subcutaneously 
into the hind paw induced biphasic pain responses.  There is no significant difference in 
licking duration between the SR-KO and WT mice during the formalin test. Values are the 
means ± SEM.  Data were analyzed by two-way RM ANOVA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S1.  Immunofluorescence localization of SR and DAPI in single optical section in 
dorsal horn of lumbar spinal cord.  (A-C) In WT mice, SR (green) is predominantly 
distributed in lamina II of the dorsal horn without formalin injection (A).  Double fluorescence 
staining of SR (green) and DAPI (blue, B) indicates that SR signals colocalize with DAPI 
nuclear staining (C).  The bar indicates 25 µm in A - C. 
 
 
